Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study
{{output}}
Background: The role biologics play in skin cancer among patients with inflammatory disease (ID) is uncertain. Skin cancer risk in patients with ID is elevated regardless of therapy, and there is a paucity of longitudinal data ev... ...
